Sir Roger Spencer Jones OBE FLSW (born 2 July 1943) is a British researcher and manager in the pharmaceutical industry.
Roger Spencer Jones was born on 2 July 1943 and brought up in a small, predominantly Welsh speaking village in the Dee valley.
[2] With but little access to capital funding, he recognised the need for Contract Development in the pharmaceutical industry and was instrumental in bringing seventeen molecules into clinical use on behalf of clients.
His unpublished work on thalidomide and his understanding of the effects of polymorphic variation on bioavailability assisted Cellgene's development of the molecule.
He was the developer of high specification activated charcoal for the treatment of acute poisoning by establishing an intestinal dialysis using the gut wall as a semipermeable membrane.